These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9509560)

  • 1. Role of neutrophils and macrophages in experimental nephrosis of the rat.
    Berens KL; Verani RR; Luke DR
    Ren Fail; 1998 Jan; 20(1):53-63. PubMed ID: 9509560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin.
    Harris KP; Lefkowith JB; Klahr S; Schreiner GF
    J Clin Invest; 1990 Oct; 86(4):1115-23. PubMed ID: 2212002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome.
    Diamond JR; Ding G; Frye J; Diamond IP
    Am J Pathol; 1992 Oct; 141(4):887-94. PubMed ID: 1415482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
    Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome.
    Eddy AA; Warren JS
    Clin Immunol Immunopathol; 1996 Feb; 78(2):140-51. PubMed ID: 8625556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of a role for inducible nitric oxide synthase in an experimental model of nephrotic syndrome.
    Walker LM; Shah SV; Mayeux PR
    Biochem Pharmacol; 2000 Jul; 60(1):137-43. PubMed ID: 10807955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis.
    Petrovic-Djergovic D; Popovic M; Chittiprol S; Cortado H; Ransom RF; Partida-Sánchez S
    Clin Exp Immunol; 2015 May; 180(2):305-15. PubMed ID: 25561167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndrome.
    Aizawa K; Takeda S; Tashiro Y; Yorozu K; Hirata M; Kanada H; Moriguchi Y; Endo K
    Am J Nephrol; 2012; 36(5):419-26. PubMed ID: 23128049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H; Shibuya T; Odashima S; Arichi S; Nagase S
    Nephron; 1988; 50(4):351-5. PubMed ID: 3237275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
    Diamond JR; Anderson S
    Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
    Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
    Tofovic SP; Rominski BR; Bastacky S; Jackso EK; Kost CK
    Ren Fail; 2000 Mar; 22(2):159-79. PubMed ID: 10803761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome.
    Eddy AA; McCulloch L; Liu E; Adams J
    Am J Pathol; 1991 May; 138(5):1111-23. PubMed ID: 2024704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
    Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
    Kikuchi M; Fujimoto S; Fukae H; Kinoshita H; Kita T; Nakazato M; Eto T
    J Am Soc Nephrol; 2005 Feb; 16(2):392-7. PubMed ID: 15590761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats.
    Ulich TR; Meline JA; Ni RX; Keys M; Wu CH
    Am J Pathol; 1987 Oct; 129(1):133-9. PubMed ID: 3499082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins.
    Li P; Yan J; Sun Y; Burczynski FJ; Gong Y
    Nephrology (Carlton); 2007 Oct; 12(5):466-73. PubMed ID: 17803470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
    Palluk R; Veress AT; Sonnenberg H
    Pharmacology; 1989; 38(4):214-25. PubMed ID: 2526952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR; Mauer SM; Michael AF
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.